Gencurix Inc. (KOSDAQ:229000)
South Korea · Delayed Price · Currency is KRW 1,634.00
-90.00 (-5.22%)
Oct 10, 2025, 3:30 PM KST
Gencurix Market Cap
Gencurix has a market cap or net worth of 26.34 billion as of October 10, 2025. Its market cap has decreased by -41.73% in one year.
Market Cap
26.34B
Enterprise Value
28.94B
Revenue
3.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,634.00
Market Cap Chart
Since April 5, 2017, Gencurix's market cap has decreased from 73.36B to 26.34B, a decrease of -64.10%. That is a compound annual growth rate of -11.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 26.34B | -12.30% |
| Dec 30, 2024 | 30.03B | -64.40% |
| Dec 28, 2023 | 84.35B | 82.80% |
| Dec 29, 2022 | 46.15B | -60.69% |
| Dec 30, 2021 | 117.40B | 11.19% |
| Dec 30, 2020 | 105.58B | 18.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |